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ABSTRACT 
The potential role for Neuropeptide Y Y5 receptor activation in the prolongation of 
lactational infertility induced by food restriction 
Nicole Bellefontaine 
Food restricted lactating rats show a prolonged period of lactational infertility. 
Previous studies suggest that at least part of this effect is due to prolonged suppression of 
pulsatile release of luteinizing hormone (LH) that results from the combined effects of 
high circulating levels of progesterone and some, as yet unidentified, neurohormone. 
There is converging evidence to suggest that Neuropeptide Y (NPY) acting through its 
Y5 receptor subtype inhibits the reproductive axis. The hypothesis that Y5 receptor 
activation prolongs lactational infertility was tested in Experiment 1. In Experiment 2, the 
combined effects of Y5 receptor inactivation and administration of the progesterone 
receptor blocker RU486 were investigated. In both experiments production of the Y5 
receptor was blocked by administration of antisense oligodeoxynucleotides (ODNs) 
targeted to the Y5 receptor from days 13-20 postpartum to food restricted (FR) dams. 
Vehicle-, scrambled ODN- treated FR and ad libitum (AL) fed dams served as controls. 
In Experiment 2, Y5 antisense and scrambled ODNs were co-administered with RU486 
(5mg/kg). Length of lactational diestrous was significantly shorter in FR dams treated 
with Y5 antisense ODNs than any other FR groups. Maternal weight gain and pup growth 
was also reduced in Y5 antisense ODN treated dams. All females treated with RU486 
displayed a length of lactational infertility similar to that seen in AL dams. Together 
these results suggest that both progesterone and Y5 receptor inactivation is effective in 
reducing the length of lactational anovulation, although whether they have direct effects 
on LH secretion remains to be determined. 
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Introduction 
The reproductive axis of mammals has adapted to respond to drastic fluctuations 
in energy availability, whether these fluctuations are unpredictable or have a seasonal 
pattern. The fertility period of seasonal breeders generally coincides with periods of high 
energy availability, thus allowing lactating females to meet the energetic demands 
associated with lactation and maximize survival of the offspring. Seasonal breeders use 
cues such as an increase in photoperiod and temperature, to signal the onset of the fertile 
period (Bronson, 1989). Many species that are not under such severe annual reproductive 
constraints, such as some rodents and primates, are influenced by acute variation in food 
availability or energy expenditure (Hamilton and Bronson, 1986; Bronson, 1989; Lujan et 
al., 2006). Little is known about the mechanisms through which restricting energy 
availability suppresses reproductive function in these conditions. In the studies described 
in this thesis the role of a Neuropeptide Y Y5 receptor activation in these mechanisms is 
assessed in a rat model in which food restriction is combined with lactation. 
The reproductive axis 
Although the mechanism through which restricting food availability modulates 
the reproductive axis remains poorly understood, the reproductive axis itself has been 
thoroughly studied. Fertility in females is based on a cyclical pattern of maturation of 
eggs, ovulation, and luteinization of the granulosa cells of the ovary, although the length 
of the cycle can vary greatly from species to species. In rats, the reproductive cycle is 
called the estrous cycle and has four distinct phases: diestrous 1, diestrous 2, proestrous, 
and estrous. Each phase of the estrous cycle has a distinct hormonal profile and is highly 
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correlated with changes in vaginal cytology. Low levels of circulating estrogen and 
progesterone characterize the diestrous 1 phase and, as the cycle progresses to diestrous 
2, estrogen levels begin to rise. During the proestrous phase of the cycle, circulating 
estrogen levels continue to rise reaching a peak in the afternoon and then fall rapidly. On 
the evening of proestrous, progesterone levels sharply increase, and ovulation typically 
takes place halfway through the dark phase. During the estrous phase of the cycle, 
circulating estrogen levels remain low and a decrease in progesterone levels is seen if 
mating does not occur (Bronson, 1989). Corresponding to the hormonal fluctuations, 
changes in vaginal cytology are also seen across the estrous cycle. The diestrous 1 
vaginal smear is marked with leukocytes, few nucleated epithelial cells, and few cornified 
epithelial cells. Similarly, diestrous 2 phase of the cycle is characterized by leukocytes 
and few nucleated epithelial cell. The proestrous phase is marked with a dramatic 
increase of nucleated epithelial cells, and conversely a decrease of leukocytes are seen, 
and estrous is characterized by the presence of cornified epithelial cells on its vaginal 
smear (reviewed by Westwood, 2008). 
Control of these events requires the coordinated activity of the hypothalamus, 
pituitary and ovary, which is frequently referred to as the hypothalamo-pituitary-gonadal 
axis (HPG). Hypothalamic control is exerted through the secretion of gonadotropic 
releasing hormone (GnRH). GnRH neuronal cells bodies are widely dispersed through 
the anterior hypothalamus, although the median preoptic nucleus (MPN) and the organum 
vasculosum of the lamina terminalis (OVLT) are known to have concentrated regions of 
GnRH neuronal perikarya. GnRH neurons project to the median eminence where GnRH 
is released into the hypophyseal portal system, at a rate of one pulse per hour. In the 
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anterior pituitary, GnRH acts on specialized neurosecretory cells, the gonadotropes, to 
stimulate the synthesis and release of pulsatile luteinizing hormone (LH) and follicle 
stimulating hormone (FSH). Pulsatile LH promotes follicular development and 
steriodogenesis within the ovary. Notably, pulsatile LH secretion causes an increase in 
release of estradiol, an increase in the number of atretic large follicles and an increase in 
percent of growing follicles in the ovaries compared to tonic release of LH, suggesting 
that ovarian responsiveness to LH is dependent on the pulsatile pattern. Estrogen, 
primarily estradiol, is secreted from the developing follicle, and is responsible for 
providing positive feedback to GnRH neurons, which initiate the LH surge required for 
ovulation. However, during the follicular phase when estradiol levels are low, estrogen 
primarily provides negative feedback (Clarkson and Herbison, 2009; Moenter et al., 
2009). 
As described by Clarkson and Herbison (2009), estrogen receptor a (ERa), the 
receptor mediating the positive feedback effects of estradiol, is not expressed on GnRH 
perikarya. However, ERa is expressed on neurons within the anteroventral 
periventricular nucleus (AVPV) that have direct projections the GnRH cell bodies and on 
other neurons that synapse onto GnRH neurons. Thus estradiol can indirectly stimulate 
GnRH neurons, providing the positive feedback that is required for these neurons to 
initiate the LH surge. In addition to indirectly stimulating GnRH to initiate the LH surge, 
estradiol also acts to upregulate progesterone receptors within the AVPV and 
progesterone also modulates GnRH release indirectly. The acute surge of progesterone 
seen on the evening of proestrus potentiates the positive feedback effects of estradiol, 
thus further stimulating the LH surge in order to trigger ovulation. However, chronic 
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progesterone stimulation or progesterone administration prior to increases in estrogen 
inhibit the ability of estrogen to stimulate GnRH release and hence to produce an LH 
surge (Clarkson and Herbison, 2009). 
Energy availability and the reproductive axis 
Numerous studies have demonstrated that restricting access to food suppresses 
reproductive function. In mice timing of puberty is affected by food restriction (Hamilton 
and Bronson, 1986), and both acute food deprivation and chronic food restriction can 
suppress reproductive cyclicity in female rats (Knuth and Friesen, 1983; Cagampang et 
al., 1990). Similarly, dietary food restriction resulting in a 15-20% decrease of body 
weight in female rhesus monkeys can inhibit ovulation (Lujan et al., 2006). In humans, 
the menstrual cycle is disrupted in women with anorexia nervosa and cyclicity is restored 
upon refeeding of the patient (Stewart, 1992). 
There are several pathways through which undernutrition could act to inhibit LH 
release, however, in most cases, the specific deficits induced by food restriction are 
assumed to arise in the hypothalamus to stimulate changes in LH release. A hypothalamic 
deficit has been confirmed in a number of models by demonstrating that food restricted 
animals that show a suppression of LH still respond to exogenously administered GnRH 
(Ebling et al., 1990). Early work by Bronson demonstrated that pulsatile LH could be 
suppressed in prepubertal rats by food restricting them to 50% of their expected food 
intake. However, within 12 to 24 hours following refeeding females displayed pulsatile 
LH secretion and ovulated within 3 to 4 days (Bronson, 1986). Later work by Wade and 
his colleagues has shown that a 48 hour food deprivation during metestrous and diestrous 
can delay ovulation for an entire estrous cycle in hamsters (Schneider and Wade, 1989). 
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Food restriction or food deprivation itself is not the only way that energy 
available for reproduction is reduced. As Bronson has pointed out ovulation is also 
suppressed in conditions where females divert nutrients towards other energy demanding 
activities. For example, high levels of exercise such as that seen in long distance runners 
are frequently associated with secondary amenorrhea (Prior et al., 1982). Perhaps the 
most energetically demanding phase of the life of a female mammal is lactation and in 
many species this period is also associated with a suppression of fertility. The length of 
this period of infertility, called lactational diestrous in rats, is dependent on suckling 
stimulation and cues of energy availability (Smith and Grove, 2002). For a rat fed ad 
libitum and suckling eight pups lactational anovulation lasts for about 20 days and its 
duration increases with the number of young suckled (Woodside and Popeski, 1999). In a 
wide number of species including humans the length of lactational infertility is increased 
when food is restricted. For example, previous studies from this laboratory have shown 
that food restricting lactating rats to 50% of a previously ascertained ad libitium food 
intake for the first 14 days postpartum increases the length of lactational infertility from 
20 to 25-27 days (Woodside, 1991). In ad libitum fed rats lactation is accompanied by 
high levels of circulating prolactin and progesterone, low levels of estrogen, and a 
suppression of pulsatile LH secretion (Smith and Fox, 1984). In addition, estrogen 
positive feedback is suppressed (Smith, 1978a). The prolonged period of anovulation 
observed in food restricted lactating rats is associated with a longer period of high levels 
of progesterone secretion as well as longer periods of low circulating LH and a 
hyposensitivity to the positive feedback effects of estrogen (Woodside, 1991; Walker et 
al., 1995; Abizaid et al., 2003). 
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Given the inhibitory effects of progesterone on the HPG, the high circulating 
levels of progesterone during lactation would be expected to have a suppressive effect on 
GnRH neuronal activity and hence LH release, as well as suppressing estrogen positive 
feedback. Evidence to support this comes from studies showing that ovariectomy or 
treatment with the progesterone receptor blocker RU486 increases pulsatile LH secretion 
and the restores the positive feedback effects of estrogen in ad libitum fed rats on day 15 
postpartum (Lee et al., 1989; Walker et al., 1995; Abizaid et al., 2003). Interestingly, 
although RU486 treatment restores estrogen positive feedback in food restricted dams on 
day 15 postpartum, neither ovariectomy nor RU486 treatment increase pulsatile LH 
secretion (Walker et al., 1995; Abizaid et al., 2003). These data suggest that in food-
restricted dams there is another source of inhibition on the reproductive axis. 
What is NPY? 
Increasingly, a number of studies have suggested that the Neuropeptide Y (NPY) 
system plays a critical role in modulating the reproductive axis. NPY is a 36 amino-acid 
peptide that is synthesized in neurons in the arcuate nucleus (ARC), the brain stem and 
throughout the cortex. Within the ARC most NPY neurons coexpress Agouti-related 
peptide (AgRP), which is an endogenous antagonist of a-melanocyte stimulating 
hormone (a-MSH) at the melanocortin-3 (MC3) and melanocortin-4 (MC4) receptors (as 
reviewed by (Smith and Grove, 2002). 
NPY is both the most abundant neuropeptide in the brain and the most potent 
orexigenic peptide known. Importantly for its role in energy balance, NPY expression in 
the ARC and release at terminal regions increases dramatically during periods of negative 
energy balance (Malabu et al., 1994). NPY fibers project from the ARC to several sites in 
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the hypothalamus including the paraventricular nucleus (PVN), perifornical, dorsomedial 
hypothalamus (DMH), and ventromedial hypothalamus (VMH), as well as other regions 
including the CA3 region and dentate gyrus (DG) of the hippocampus and nucleus 
accumbens and putamen (Allen et al., 1983). 
The actions of NPY are mediated through six receptor subtypes: Yl, Y2, Y3, Y4, 
Y5, and Y6.The Y6 receptor subtype has only been cloned in mice and in the rat, only 
Yl, Y2, Y4, and Y5 receptors are found in the brain. These receptors are pancreatic 
polypeptide preferring receptors, and belong to the G-coupled protein receptor subfamily 
that, when activated, cause an inhibition of adenylate cyclase and in some cases 
activation of the protein kinase C pathway (Parker et al., 1998; Smith and Grove, 2002). 
Chronic infusion of NPY into the ventricles induces robust hyperphagia and similar 
effects occur when NPY is injected directly into the VMH, PVN, or perifornical nuclei 
(Stanley and Leibowitz, 1984; Stanley et al., 1985; Stanley and Thomas, 1993). In 
addition, central injections of NPY can suppress thermogenesis in brown adipose tissue 
(BAT), and decrease sympathetic nervous system activation (Billington et al., 1991). It 
has even been reported that NPY administration can elicit whole body hypothermia (Ruiz 
de Elvira and Coen, 1990). 
There is strong evidence that NPY elicited food intake is mediated by the Yl and 
Y5 receptor subtypes. Treatment with a specific Yl agonist, [Leu31, Pro34]NPY, 
increases food intake, and central injection of a Yl antagonist, 1229U91, inhibits NPY 
induced food intake (Kalra et al., 1991; Kanatani et al., 1996). Infusion of a Y5 agonist, 
D-[Trp32]-NPY, increases feeding and decreases BAT temperature. Further, rats treated 
with a chronic infusion of antisense oligodenucleotides against the Y5 receptor also 
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displayed a reduction in food intake (Campbell et al., 2001). In diet- induced obese 
animals, Y5 receptor expression is upregulated and administration of a Y5 antagonist, L-
152,804, can inhibit food intake in these animals (Widdowson et al., 1997; Ishihara et al., 
2006). In contrast administration of a specific Y2 agonist suppresses food intake (Kalra et 
al., 1991). 
A second distinct subpopulation of neurons within the ARC has also been found 
to regulate food intake. These neurons contain melanocortin peptides derived from the 
proopiomelanocortin (POMC) gene. One of these peptides a-MSH, activates MC4 
receptors to inhibit food intake (for a review see (Cone, 2005)). Both the NPY/AgRP and 
POMC neurons within the ARC are considered primary targets of peripheral hormonal 
signals of satiety and hunger, such as leptin, ghrelin, and insulin (Baskin et al., 1999; 
Riediger et al., 2003; Sato et al., 2005). 
NPY and reproduction 
In addition to its role in controlling energy balance, NPY has been shown to have 
a complex interaction with the reproductive axis, producing both stimulatory and 
inhibitory effects. The ability of NPY to stimulate LH release appears to be dependent on 
the presence of ovarian hormones (Crowley and Kalra, 1987; Sabatino et al., 1989; 
Bauer-Dantoin et al., 1992). For example, in estrogen and progesterone primed 
ovariectomized rats, central infusion of NPY stimulates release of the LH surge and the 
ability of estrogen and progesterone to induce an LH surge is inhibited in the presence of 
NPY antiserum (Crowley et al., 1987; Minami et al., 1990). Further, in an in vitro study 
Levine and colleagues showed that NPY stimulates GnRH neurons to increase release but 
only in the presence of estrogen (Bauer-Dantoin et al., 1993; Besecke and Levine, 1994). 
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NPY inhibition of LH secretion, on the other hand, is seen in the absence of 
ovarian steroids or when NPY levels are chronically high, as is characteristic of states of 
negative energy balance, such as fasting or food restriction. Clarke and colleagues have 
found that chronically elevated levels of NPY, similar to those seen following food-
restriction, can block the LH surge in sheep (Estrada et al., 2003). In ovariectomized rats 
and ewes that have not been primed with estrogen and progesterone, NPY can also inhibit 
LH release. Moreover, central injection of NPY decreases the ability of ovariectomized 
rats to respond to injections of LHRH (Bauer-Dantoin et al., 1992; Estrada et al., 2003). 
In addition, our laboratory has shown that chronic infusion of NPY disrupts cyclicity and 
following removal of the NPY source, females displayed normal estrous cycles 
(Woodside et al., 2002). 
The differential effects of NPY on the HPG are, at least in part, mediated by 
activation of differing NPY receptor subtypes. It has been suggested that Yl receptor 
activation mediates the stimulatory effects of NPY on LH (Hill et al., 2004), whereas Y5 
activation is likely responsible for NPY inhibition of LH. Smith and colleagues have 
localized both Yl and Y5 receptors to areas that influence the reproductive axis. Yl 
receptors are expressed on axon terminals that synapse onto GnRH neuronal cell bodies, 
as well as GnRH terminals at the median eminence (Li et al., 1999). The Y5 receptor, 
however, is expressed in 50% of GnRH perikarya, providing a direct action of NPY on 
GnRH neuronal activation (Campbell et al., 2001). In states of negative energy balance, 
such as lactation, NPY receptor distribution and activation may be altered, thus 
influencing GnRH activation differently (Pickavance et al., 1999). 
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In contrast to the ability of chronic infusion of NPY to suppress ovulation in 
cycling rats, in lactating dams this treatment results in an early termination of lactational 
infertility (Woodside et al., 2002). This effect is most likely mediated by Yl receptor 
activation and subsequent decrease in circulating prolactin levels. When a Yl antagonist 
was administered in conjunction with NPY infusion prolactin levels, litter growth and 
length of lactational anovulation were restored to normal levels (Toufexis et al., 2002b). 
In contrast to the effects of increasing Yl activation during lactation, administering a 
specific Y5 agonist to ad libitum fed rats actually prolongs lactational diestrous without 
producing any changes in pup growth or maternal weight gain (Toufexis et al., 2002a). 
Similar treatment prolonged the length of the estrous cycle in nonlactating rats whereas 
administering a Y2 agonist had no effect on either length of lactational infertility or 
estrous cyclicity (Toufexis et al., 2002b). Further support for the inhibitory effects of Y5 
receptor activation on the HPG comes from a recent study by Smith and colleagues. 
They showed that application of a specific Y5 antagonist, L-152,804, increases the firing 
rate of GnRH neurons of lactating dams in vitro (Xu et al., 2009). 
The current studies 
It is clear that NPY can act to inhibit the reproductive axis when circulating levels 
of estrogen levels are low, such as during lactation. Levels of NPY are increased in food 
restricted lactating dams, thus it is plausible that NPY mediated inhibition of the 
reproductive axis is responsible for the extended suppression of LH seen in these animals. 
In the current set of experiments we investigated the role of Y5 receptor activation in the 
prolongation of lactational anovulation induced by food restriction in lactating rats. 
Because the Y5 receptor is the only NPY receptor expressed on GnRH perikarya, it 
17 
provides a direct mechanism for the inhibition of GnRH release. In the first experiment 
described here, we used administration of antisense deoxyoligonucleotides (ODNs) to 
block production of the Y5 receptor and measured effects on the length of lactational 
infertility, maternal body weight and pup growth in food restricted and ad libitum fed 
dams. In addition to increases in Y5 receptor activation, and NPY release in food 
restricted lactating rats, progesterone levels are higher than those seen in ad libitum fed 
dams. Thus in the second experiment we tested the co-administration of Y5 antisense 




Female virgin Wistar rats obtained from Charles River Breeding Farms (St. 
Constant, Quebec) and weighing between 220g-280g upon arrival, were housed in group 
cages on a 12h/12h light/dark cycle (lights on 0800hr) and maintained at a temperature of 
20° ± 2°C. All rats had ad libitum access to food (Agway Ltd) and water until the start of 
the experiment. All experimental protocols were approved by the Concordia University 
Animal Care Committee under the guidelines of the Canadian Council for Animal Care. 
Mating 
Virgin females were housed five to a cage with one sexually experienced male. 
Two days prior to estimated day of parturition, each female was individually housed in a 
polyethylene cage (33 x 45 x 27 cm). 
Procedures 
Day of parturition was designated as Day 0 postpartum (pp), and on Day lpp, 
litters were culled to 8 pups (4 females and 4 males) and dams were assigned to either an 
ad libitum (AL) fed group or food restricted (FR) groups. Females assigned to the FR 
condition were fed 50% of a previously ascertained ad libitum ration for Days 1-14 pp, 
inclusive. Maternal body weight, litter weight, and food intake were recorded daily from 
Day 1 and daily vaginal smears were taken from Day 4pp onwards for all groups. 
Termination of lactational diestrous was defined as the day on which more than 70% of 
the vaginal smear was comprised of cornified epithelial cells. 
Surgery 
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On Day 13 postpartum all dams were anesthetized using a ketamine xylazine 
mixture (6mg ketamine and 1.1 mg xylazine per lOOg-body weight). A 22 gauge re-
shaped cannula was implanted into the third ventricle aimed at +0.20 mm anterior-
posterior, 0.0mm lateral to bregma, and -0.96 mm ventral from the top of the skull with 
the nosebar set 5 mm above the interaural line (Paxinos & Watson, 1986). Antisense, and 
scrambled ODNs, as well as vehicle, were chronically infused into the 3 rd ventricle via a 
7-day osmotic minipump (Alzet model 2001) attached to the side arm of the cannula by a 
4cm length of polyethylene tubing (0.030" inside diameter x 0.048" outside diameter, A-
M Systems, Inc.). The minipump was inserted into the subcutaneous interscapular space. 
The cannula was held in place by dental acrylic that was anchored to the head by four 
jeweler's screws. 
Antisense treatment 
Animals were randomly assigned to receive I.C.V microinfusions of a 0.9% saline 
vehicle, Y5 antisense oligonucleotides (ODN), or an equivalent scrambled ODN to the 
Y5 receptor. The antisense sequence to the Y5 receptor used was 5'-
AAGAGGACGTCCATTAGC-3', and the equivalent scrambled sequence was 5'-
AGTCAGTCTGCGAAGCAA-3'. These sequences were chosen based on the previously 
published work of Campbell et al (2001) who showed that treatment with this antisense 
ODN produced a decrease in food intake and that the scrambled sequence did not. Both 
ODNs (synthesized by Sigma Genosys, Canada) were phosphorothioated at all positions 
to increase resistance to exo- and endo-nucleases and were diluted in sterile saline such 
that rats received 10 jj.g (1.8 nmol)/rat/24 hour). 
Histology 
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To ascertain correct cannula placement, all rats were given a lethal dose of 
sodium pentobarbital (60mg/rat) and sacrificed by intracardiac infusion with 0.9% saline 
followed by 10% formal-saline. Brains were extracted, saturated for 48 hours in 30% 
formalin-sucrose solution and stored at -80°C before sectioning. Sections were mounted 
on gelatin-coated slides and viewed for correct placement of the cannula using a Leica 
DMR-HC microscope. Data from rats that were found to have a misplaced cannula were 
eliminated from the study. 
Experiment 1: Effect of treatment with ODN antisense to the Y5 receptor on length of 
lactational infertility 
To investigate the effects of blocking production of the NP Y Y5 receptor on the length 
of lactational fertility in food restricted rats, food restricted dams were assigned to one of 
three groups: FR- vehicle (N= 7), FR Antisense ODN (N= 6), and FR Scrambled (N= 7). 
A fourth group of ad libitum fed vehicle-infused lactating rats were included as an 
additional comparison. Food intake as well as maternal body weight and litter weight and 
vaginal cytology were recorded daily until day 25 pp, when rats were killed and histology 
was performed as described above. 
Experiment 2: Effect of combined treatment with ODN antisense to the Y5 receptor and a 
progesterone receptor blocker on length of lactational infertility 
The effect of co-administration of Y5 antisense ODNs and progesterone receptor 
blockade on the length of lactational anovulation was assessed using the same procedures 
as described for Experiment 1 except that food restricted females were assigned to one of 
four groups: FR- vehicle - oil (N=6), FR - vehicle - RU486 (N=6), FR-Antisense-
RU486 (N=5), FR-Scrambled- RU486 (N=7). As in Experiment 1, ad libitum fed vehicle-
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infused dams were added as a comparison. On days 15-18pp, inclusive, dams were 
administered daily subcutaneous injections at 0900h and 2100h of either RU486 
(5mg/kg) dissolved in 100% ethanol (2mL/100g) or an oil vehicle consisting of 100% 
ethanol and sesame oil. On day 25 dams were sacrificed as described above. 
Statistical Analysis 
To confirm that groups were similar prior to treatment, a one-way ANOVA for 
maternal body weight gain between days 1-13 pp was performed, as well as a one-way 
ANOVA for pup growth between days l-13pp. To evaluate the effects of treatment a 
one-way ANOVA was performed for each dependent variable: length of lactational 
diestrous, maternal body weight change during treatment (days 13-20), and litter growth 
during treatment (days 13-20 pp). Where appropriate pairwise posthoc comparisons 
were performed using Fisher's Least Significant Difference. 
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Results 
Experiment 1: Role of the Y5 receptor activation in the prolongation of lactational 
diestrous induced by food restriction 
Pretreatment 
As expected ad libitum fed postpartum rats weighed more than FR rats at the time 
of surgery resulting in an overall significant effect of group (F (3, 21) = 42.153, p<0.05). 
There were no significant differences among the FR groups at this time (p>0.05). 
Similarly, litters nursed by ad libitum fed dams grew faster than those nursed by FR dams 
(F (3,20) = 18.507, p<0.05) but growth rate of litters nursed by dams in the different FR 
groups did not differ prior to treatment (pairwise post hoes p>0.05). 
Effects of Treatment 
Figure 1 shows length of lactional diestrous varied across groups (main-effect of 
treatment (F (3, 20) = 14.276, p< 0.05). As expected ad libitum fed rats showed a shorter 
period of lactational infertility than FR-veh treated rats. In addition treatment of FR rats 
with Y5 antisense ODN significantly reduced the length of lactational diestrous when 
compared to both the scrambled ODN and vehicle FR groups (pairwise post hoes 
p<0.05). The scrambled ODN groups also displayed a shorter anovulation period when 
compared to the FR vehicle group (p<0.05). 
As shown in Figure 2, treatment with Y5 antisense reduced maternal weight gain 
during treatment compared to all other groups (main effect of treatment F (3,21) = 26.24, 
p<0.05,), pairwise post hoc p<0.05). All FR groups had a significantly greater weight 
gain during treatment than ad libitum fed dams (p<0.05), due to the post-fast increase in 
food intake. As Figure 3 shows, pups nursed from Y5 antisense treated dams have a 
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reduced litter weight gain during treatment (main effect of treatment (F (3,19) = 4.418, 
p<0.05), pairwise post hoc p<0.05) compared to all other groups. There was no 
difference in growth between litters nursed by scrambled treated dams, or those nursed 
from FR vehicle treated or ad libitum fed vehicle treated dams. 
Experiment 2: Effect of co-administration ofY5 antisense and RU486 on the length of 
lactational diestrous induced by food restriction 
Pretreatment 
As predicted, ad libitum fed postpartum dams weighed more at the time of 
surgery than food restricted dams (F (4,24) = 31.836, p<0.05). However, there were no 
significant differences between food restricted groups at this time (pairwise post hoes 
p>0.05). Litters nursed by ad libitum fed dams similarly had an increased litter weight 
gain compared to those nursed from food restricted dams at the time of surgery ( F (4,24) 
= 54.519, p<0.05). There were, however, no differences in litter weight gain among the 
food restricted groups (pairwise post hoes p>0.05). 
As shown in Figure 4, treatment with RU486 shortened the length of lactational 
infertility in FR dams when compared to FR vehicle treated dams (main effect of 
treatment F (4, 24) = 11.534, p<0.05, pairwise post hoes p<0.05). Length of lactational 
diestrous in RU486 -treated FR dams did not differ from ad libitum fed vehicle dams 
(p>0.05). Combined treatment with AS and RU486 had no additional effect on length of 
lactational diestrous. 
As displayed in Figure 5, treatment with Y5 antisense and RU486 reduced 
maternal body weight when compared with FR vehicle-vehicle, FR vehicle-RU486, and 
AL-vehicle dams (main effect of treatment F (4,24) = 26.451, p<0.05, pairwise post hoes 
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p<0.05). Further, there was a trend for FR-Y5 antisense-RU486 to gain less during 
treatment than FR-scrambled ODN-RU486 (p=0.10). Ad libitum fed dams gained less 
weight during treatment when compared to all other groups (p<0.05), which is most 
likely due to lack of a post-fast increase in food intake. As shown in Figure 6, litters 
nursed from ad libitum fed mothers gained significantly more weight during treatment (F 
(4,24,) = 4.821, p<0.05, pairwise post hoes p<0.05) when compared with all other groups. 
There was, however, no difference in litter weight gain during treatment for pups nursed 
among FR groups (p>0.05). 
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Discussion 
It is clear that NPY plays a role in several biological functions, including control 
of energy balance and modulation of reproduction. The current study assessed the role of 
NPY Y5 receptor activation in the prolongation of lactational infertility induced by food 
restriction. Here we demonstrate that blocking production of the Y5 receptor via 
antisense ODNs decreases the length of lactational infertility in food restricted dams 
when compared to those treated with scrambled ODNs or vehicle. To our knowledge this 
is the first direct demonstration that Y5 activation is involved in the suppression of the 
HPG axis during times of low food availability. In addition to its potential influence on 
the HPG axis, we also show that maternal weight gain and litter weight gain is reduced 
when dams are treated with Y5 antisense ODNs. In addition in Experiment 2, we show 
that there were no additive effects on length of lactational anovulation when Y5 antisense 
ODN treatment was combined with progesterone receptor blockade. 
The reduced length of lactational infertility seen in Y5 antisense treated dams is 
consistent with the hypothesis that Y5 receptor activation mediates the inhibitory effects 
of NPY on the HPG axis. As food restricted lactating rats show increased NPY protein 
expression in the ARC (Pickavance et al., 1996; Abizaid et al., 1997) and an a greater 
density of the Y5 receptor subtype within the MPOA than ad libitum fed rats (Walker et 
al., 1999), NPY is in a direct position to suppress LH release through Y5 receptor 
mediated inhibition of GnRH neurons. Indeed, using an in vitro preparation, Smith and 
colleagues have shown that during lactation Y5 receptor antagonism reduces NPY 
inhibition of GnRH neuronal activity (Xu et al., 2009). The current results are consistent 
with the notion that when Y5 receptor activation is decreased GnRH is released from 
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NPY-induced inhibition, and thus LH pulsatility is restored. However, the length of 
lactational anovulation is a function of both pulsatile LH secretion and the ability of 
estrogen to stimulate an ovulatory surge in LH, thus to confirm the hypothesis, Y5 
antisense ODN treatment is having its effects through changing pulsatile LH release this 
would need to be examined directly (Smith, 1978a, b; Fox and Smith, 1984). 
Treatment with Y5 antisense ODNs also decreased maternal body weight and 
litter weight gain. Previous studies have demonstrated that infusion of Y5 antisense 
ODNs decreases food intake in lactating rats, as well as in males (Campbell et al., 2001; 
Ladyman and Woodside, 2009). Thus, it is possible that the reduction in body weight 
gain observed in Y5 antisense ODN-treated rats results from a decrease in post food 
restriction intake. The early return to cyclicity in this group is particularly impressive 
because one would expect that the decreased post-fast intake would result in a longer 
period of negative energy balance and, in fact, further prolong lactational infertility. 
Although the results of Experiment 1 are consistent with the idea that NPY is 
acting directly on the HPG through the Y5 receptor, recent evidence suggests that other 
pathways could be involved. Interestingly, chronic infusion of Y5 antisense ODNs to ad 
libitum fed dams results in changes to mother-litter interactions, such that dams spend 
less time on their nest and have shorter nest bouts. It is also associated with both a 
reduction in litter growth and reduced prolactin concentrations in antisense-treated dams, 
presumably because the reduction in nest bout duration is associated with fewer milk 
ejections (Ladyman and Woodside, 2009). Although food restricted dams spend more 
time with their pups than ad libitum fed dams do, simply reducing nest time is unlikely to 
account for the reduction in length of lactational infertility because direct manipulation of 
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nest bout length is ineffective in changing length of lactational infertility in food 
restricted rats (Woodside and Jans, 1995). However, the effect of Y5 receptor 
inactivation on maternal behavior needs to be clarified. In addition, it will be important to 
determine whether treatment with Y5 receptor antisense ODNs changes circulating levels 
of other hormones such as prolactin and progesterone which are known to influence the 
reproductive axis (Woodside, 2007). 
Although no measures of the effects of antisense ODN treatment on Y5 receptor 
levels are included in this thesis, these effects have been well-documented in previous 
studies both from this laboratory and others. For example, Campbell et al (2001) have 
used immunoblotting to show a decrease in Y5 receptor protein levels in the PVN and the 
VMH of male rats following administration of the same Y5 antisense ODN sequence 
used in these studies (Campbell et al., 2001). In our laboratory, using a different Y5 
receptor antibody, we demonstrated that administration of Y5 antisense ODNs decreased 
the number of Y5 immunoreactive cells in the PVN (Ladyman and Woodside, 2009). 
The high levels of circulating progesterone typical of rats in early and mid 
lactation provide a major source of negative feedback on to GnRH and LH release 
(Smith, 1981; Lee et al., 1989; Attardi et al., 2007). Eliminating the influence of 
progesterone results in an increase in LH levels in ad libitum fed rats on Day 15 of 
lactation but has no effect in food restricted rats at this time (Walker et al., 1995). The 
results of Experiment 1 are consistent with the idea that Y5 receptor activation is 
providing an additional source of inhibition on the HPG at this time. In Experiment 2 the 
possibility that an additive inhibitory effect of Y5 and progesterone receptor activation on 
the HPG would be revealed by administering the Y5 antisense ODN and progesterone 
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receptor antagonist simultaneously. However, we observed no additive effects of Y5 
antisense treatment when combined with RU486 on the length of lactational infertility. 
Rather RU486 administration alone was sufficient to reduce the length of lactational 
infertility in food restricted rats to the level seen in ad libitum fed rats. 
These data would, at first glance, appear to contradict earlier results suggesting 
that removing progesterone negative feedback is not sufficient to restore LH levels in 
food restricted rats (Walker et al., 1995). It is possible, however, that these apparent 
inconsistencies are simply a result of when the RU486 was administered relative to the 
food restriction schedule. In the current study RU486 was administered during refeeding 
when the inhibitory effects of Y5 receptor activation might be expected to be waning. 
Perhaps to demonstrate an additive effects of these two factors on LH secretion it would 
be best to administer them earlier in lactation i.e. prior to Day 15 postpartum. 
As well as exerting negative feedback on LH secretion, high progesterone levels 
also suppress estrogen positive feedback hence RU486 administration would be expected 
to increase both pulsatile LH secretion and restore sensitivity to estrogen positive 
feedback to the resulting increase in estrogen secretion from the developing follicles (Lee 
et al., 1989). Thus the ability of RU486 treatment to decrease the length of lactational 
infertility probably reflects both an increase in pulsatile and surge release of LH. At 
higher dose ranges RU486 is a potent glucocorticoid antagonist, the dose used in this 
experiment, however, fell well below those that have been shown to block glucocorticoid 
receptors (De Kloet et al., 1988; Ratka et al., 1989). 
Combining RU486 treatment with Y5 antisense administration did not alter the 
effect of the latter treatment on maternal weight gain. However, there were no effects of 
29 
Y5 receptor inactivation on pup growth in Experiment 2, whether this simply reflects 
differences across experiments or the ability of RU486 to reduce the effects of Y5 
receptor inactivation on pup growth needs to be assessed directly. 
Although chronic administration of Y5 antisense ODNs reduced the length of 
lactational infertility in food restricted dams, chronic administration of scrambled ODNs 
also resulted in a shorter length of lactational anovulation suggesting a non-specific effect 
of ODN treatment. Such non specific effects of ODN administration have been observed 
in a number of studies and have been particularly associated with phosphothioration 
(Guvakova et al., 1995; Achenbach et al., 2003; Fichou and Ferec, 2006). Alternative 
approaches would include the use of siRNA or a specific receptor antagonist (Achenbach 
et al., 2003). There are no reports in the literature of a siRNA for the Y5 receptor and the 
limited penetration of these together with the fact that GnRH neurons tend to be dispersed 
throughout the OVLT/MPOA region this approach presents some problems (Campbell, 
2007). A number of specificY5 antagonists have been described but on closer 
examination have been shown to have Y5-independent effects. For example, a commonly 
used Y5 antagonist CGP 71683A has been shown to be effective in reducing food intake 
in Y5 knockout mice, as well as displaying a high affinity for serotonin reuptake 
transporters and muscarinic receptors suggesting this drug acts to reduce food intake 
through a mechanism other than Y5 receptor blockade (Delia Zuana et al., 2001; Della-
Zuana et al., 2004). In parallel with the current studies, we have tested the behavioral 
effects of a new highly specific Y5 antagonist, L-152,804, that has been shown to reduce 
NPY induced food intake in mice, reduce intake in diet-induced obese mice but not lean 
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ones and to be ineffective in Y5 receptor knockout mice, (Kanatani et al., 2000; Ishihara 
et al., 2006; Takahashi et al., 2006). We have recently shown that this antagonist also 
reduces food intake in dietary-induced obese female rats. In future studies, we will 
evaluate the ability of this antagonist to change LH secretion in food restricted lactating 
rats. 
One assumption when using any approach that changes activation of one receptor 
subtype is that activity of the other receptor subtypes is not affected. Campbell et al 
(2001) showed no effect of Y5 antisense ODN treatment on Y2 receptor protein density 
(Campbell et al., 2001). Thus far, however, no one has assessed whether interfering with 
Y5 receptor activation either by administering an antagonist or an antisense ODN affects 
Yl receptor density or activation. Given the role that the Yl receptor plays in the control 
of PRL release and its putative role in the control of GnRH release such effects would be 
particularly important to evaluate in the current context (Toufexis et al., 2002b; Hill et al, 
2004). 
The results of the current studies suggest that both Y5 receptor activation 
and high levels of circulating progesterone play critical roles in the control of lactational 
infertility in food restricted rats. In addition they support previous data suggesting that Y5 
receptor activation plays a critical role in regulating energy balance. This is the first 
study to demonstrate a direct role for the activation of the Y5 receptor on the HPG axis 
during food restriction and it remains to be determined whether it makes a similar 
contribution to other situations e.g in the effects of food restriction on delay of puberty 
(Bronson, 1986). In addition, early in lactation both ad libitum fed and food restricted 
dams fail to show a post-castration rise in LH levels (Walker et al., 1995). Given the 
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inhibitory role of NPY on LH secretion in times when estrogen levels are low, as well as 
the current data suggesting that Y5 receptor activation mediates NPY inhibition on GnRH 
neurons to suppress LH secretion during mid to late lactation in food restricted rats, it is 
possible that NPY, acting through the Y5 receptor, is the major source of inhibition on 
GnRH neurons early in lactation for both ad libitum fed and food restricted dams. Future 
studies will evaluate this possibility to further define the relative contributions of NPY, 


















Figure 1. Length of lactational infertility measured in days (mean ± standard error). Stars 
represent significance from all other groups. Pound sign represents differences between 
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Figure 2. (A) Maternal body weight gain (g) during treatment (means ± standard error). 












































<j>- — O f **l" 
13 14 15 16 17 18 19 20 
— • - F R + V 
- * - F R + A S 
- ! * - F R + S C 
- G - A L + V 
D a y pos tpa r tum 
Figure 3. (A) Litter weight gain (g) during treatment (means ± standard error). (B) Litter 
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Figure 4. Length of lactational infertility measured in days (mean ± standard error). Stars 
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